Business Wire - July 13, 2004
Vencor's AtHomeDiagnostics.com offers the only HIV-1 and Hepatitis C tests approved by United States Food and Drug Administration (FDA) to be sold direct to consumers, manufactured by Home Access Health Corporation, Hoffman Estates, Ill. AtHomeDiagnostics.com also offers the FDA approved Home Access(R) Instant Cholesterol test kit and FDA approved MyAllergyTest(TM). MyAllergyTest(TM) is the world's first home allergy test developed and manufactured by ImmuneTech, Inc., Menlo Park, CA.
FDA Approved At Home Tests Focus On Life Threatening Diseases
"The Home Access(R) manufactured HIV-1 and Hepatitis C diagnostic tests are the only FDA Approved tests for these life threatening diseases that are approved for sale direct to consumers for use at home in the United States. The recent FDA approval of OraSure Technologies' OraQuick(R) HIV-1/2 test earlier this year seems to have confused people as to its use and availability. The OraQuick(R) HIV-1/2 test is FDA approved but only for use under the supervision of healthcare professionals. This means that the only HIV test approved by the FDA to be sold, purchased by and performed by consumers themselves are the Home Access(R) HIV tests," noted Paul Fasi, AtHomeDiagnostics.com Managing Director.
Vencor will be initiating development of a Spanish language version of the AtHomeDiagnostics.com web site. The Spanish language version of the AtHomeDiagnostics.com web site will be used for Spanish speaking people in the USA and to launch AtHomeDiagnostics.com sales in Mexico, Central and South America.
About Vencor
Vencor, in addition to the E-commerce sales of at-home diagnostic products to consumers in the US and infectious disease rapid tests to healthcare professionals in the emerging healthcare markets, recently expanded into the manufacturing and distribution of healthcare apparel and materials to primary US and international markets.
Safe Harbor Statement
The information contained in this press release, including "forward-looking statements" within section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the company's annual report, financial filings and other publicly available information regarding the company, copies of which are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business, and such statements, including risks and uncertainties related to that, are unpredictable and outside of the influence and/or control of the company.
CONTACT: Vencor International, Inc.
Paul Fasi, 310-289-3488, Paul.Fasi@vencorinternational.com
or
The Haft Group, Inc.
Herb Haft, 212-759-8865 (Investor Relations), HerbHaft@aol.com
SOURCE: Vencor International, Inc.
040713
BW040710
Copyright © 2004 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .